Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID‐19: Experience from London
Journal of Internal Medicine Sep 26, 2020
Vaid N, Ardissino M, Reed TAN, et al. - Researchers investigated if and how the use of immunosuppressant medication is associated with outcomes of patients hospitalized with COVID‐19. Among 981 assessed patients who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), 354 (36.1%) patients died during the follow‐up period. Observations revealed significantly higher mortality rates in the immunosuppressed cohort (n = 31). The current UK government’s early isolation ('shielding') policy for these individuals was thus further supported by the results.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries